[Measurement of serum concentration of digoxin by radioimmunoassay--emphasis on renal failure patients (author's transl)]. 1980

S Iida, and Y Kawamura, and M Fukumoto, and J Yamazaki, and S Suzuki

UI MeSH Term Description Entries
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D004077 Digoxin A cardiotonic glycoside obtained mainly from Digitalis lanata; it consists of three sugars and the aglycone DIGOXIGENIN. Digoxin has positive inotropic and negative chronotropic activity. It is used to control ventricular rate in ATRIAL FIBRILLATION and in the management of congestive heart failure with atrial fibrillation. Its use in congestive heart failure and sinus rhythm is less certain. The margin between toxic and therapeutic doses is small. (From Martindale, The Extra Pharmacopoeia, 30th ed, p666) Digacin,Digitek,Digoregen,Digoxina Boehringer,Digoxine Nativelle,Dilanacin,Hemigoxine Nativelle,Lanacordin,Lanicor,Lanoxicaps,Lanoxin,Lanoxin-PG,Lenoxin,Mapluxin,Boehringer, Digoxina,Lanoxin PG,Nativelle, Digoxine,Nativelle, Hemigoxine
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

S Iida, and Y Kawamura, and M Fukumoto, and J Yamazaki, and S Suzuki
February 1981, Horumon to rinsho. Clinical endocrinology,
S Iida, and Y Kawamura, and M Fukumoto, and J Yamazaki, and S Suzuki
March 1981, Radioisotopes,
S Iida, and Y Kawamura, and M Fukumoto, and J Yamazaki, and S Suzuki
November 1979, Horumon to rinsho. Clinical endocrinology,
S Iida, and Y Kawamura, and M Fukumoto, and J Yamazaki, and S Suzuki
April 1982, Horumon to rinsho. Clinical endocrinology,
S Iida, and Y Kawamura, and M Fukumoto, and J Yamazaki, and S Suzuki
August 1970, British medical journal,
S Iida, and Y Kawamura, and M Fukumoto, and J Yamazaki, and S Suzuki
January 1976, Horumon to rinsho. Clinical endocrinology,
S Iida, and Y Kawamura, and M Fukumoto, and J Yamazaki, and S Suzuki
August 1981, Kaku igaku. The Japanese journal of nuclear medicine,
S Iida, and Y Kawamura, and M Fukumoto, and J Yamazaki, and S Suzuki
March 1982, La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris,
S Iida, and Y Kawamura, and M Fukumoto, and J Yamazaki, and S Suzuki
October 1981, Pathologie-biologie,
S Iida, and Y Kawamura, and M Fukumoto, and J Yamazaki, and S Suzuki
December 1981, Pathologie-biologie,
Copied contents to your clipboard!